XtalPi Technology Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
1,623
- Stock Symbol
-
02228
- Investments
-
34
- Share Price
-
$0.75
- (As of Friday Closing)
XtalPi Technology General Information
Description
XtalPi Holdings Ltd is a research platform company powered by artificial intelligence (AI) and robotics. It is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. The company combines quantum physics, AI, cloud computing, and large-scale robotics to provide research & development solutions, services, and products for pharmaceuticals, biotechnology, renewable energy, and materials industries globally. The company has a single segment that is intelligent robotics solutions and drug discovery solutions (including one-stop drug discovery solutions). The firm generates the majority of its revenue from Drug discovery solutions, and a smaller portion of revenue is derived from AI for Science intelligent solutions.
Contact Information
Website
www.xtalpi.comCorporate Office
- 3rd Floor, Phase II, International Biomedical Industrial Park
- Number 2 Hongliu Road, Futian District
- Shenzhen, Guangdong 518000
- China
Corporate Office
- 3rd Floor, Phase II, International Biomedical Industrial Park
- Number 2 Hongliu Road, Futian District
- Shenzhen, Guangdong 518000
- China
XtalPi Technology Stock Performance
As of 13-Nov-2026, XtalPi Technology’s stock price is $0.75. Its current market cap is $3.21B with 4.3B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.75 | $0.77 | $0.71 - $1.83 | $3.21B | 4.3B | 54.5M |
XtalPi Technology Financials Summary
As of 30-Jun-2026, XtalPi Technology has a trailing 12-month revenue of $97.1M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,267,899 | 4,541,831 | 2,189,838 | |
| Revenue | 97,061 | 111,610 | 37,131 | 24,653 |
| EBITDA | (17,604) | 20,675 | (198,494) | (265,406) |
| Net Income | (30,147) | 17,208 | (211,360) | (270,589) |
| Total Assets | 1,857,943 | 1,460,326 | 596,532 | 565,091 |
| Total Debt | 458,986 | 63,152 | 20,378 | 36,109 |
XtalPi Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
XtalPi Technology Comparisons
Industry
Financing
Details
XtalPi Technology Competitors (23)
One of XtalPi Technology’s 23 competitors is BenevolentAI, a Formerly PE-Backed company based in Luxembourg, Luxembourg.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BenevolentAI | Formerly PE-Backed | Luxembourg, Luxembourg | ||||
| InSilico Medicine Cayman | Formerly VC-backed | Hong Kong, Hong Kong | ||||
| Medkey | Private Equity-Backed | Shanghai, China | ||||
| Iktos | Venture Capital-Backed | Paris, France | ||||
| Avid Bioservices | Private Equity-Backed | Tustin, CA |
XtalPi Technology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
XtalPi Technology Patents
XtalPi Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026171065-A1 | Method for predicting molecular concentration, method for calculating reaction yield, and related products | Pending | 14-Feb-2025 | ||
| WO-2026157116-A1 | Flash filtration device and experimental platform | Pending | 27-Jan-2025 | ||
| WO-2026157116-A9 | Flash filtration device and experimental platform | Pending | 27-Jan-2025 | ||
| US-20260219144-A1 | Flash-filtration apparatus and experimental platform | Pending | 27-Jan-2025 | ||
| WO-2026149370-A1 | Crystallization method for metformin ascorbate | Pending | 07-Jan-2025 |
XtalPi Technology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
XtalPi Technology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
XtalPi Technology Investments & Acquisitions (34)
XtalPi Technology’s most recent deal was a Later Stage VC with RabbitPre. The deal was made on 07-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RabbitPre | 07-May-2026 | Later Stage VC | Media and Information Services (B2B) | ||
| Xellar Biosystems | 01-Apr-2026 | Early Stage VC | Discovery Tools (Healthcare) | ||
| Dingxi Zhichuang | 25-Mar-2026 | Early Stage VC | Multimedia and Design Software | ||
| Deep Principle | 04-Mar-2026 | Early Stage VC | Business/Productivity Software | ||
| Leman Biotech | 04-Mar-2026 | Early Stage VC | Drug Discovery |
XtalPi Technology ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
22.19 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
XtalPi Technology Exits (3)
XtalPi Technology’s most recent exit was on 12-Jun-2025 from LCC Therapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| LCC Therapeutics | 12-Jun-2025 | Completed |
|
||
| METis TechBio | 09-Jul-2021 | Completed |
|
||
| METis TechBio | 08-Dec-2020 | Early Stage VC | Completed |
|
XtalPi Technology Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| LCC Therapeutics | Runcorn, United Kingdom | 2014 | |
| Siwei Medical | Shanghai, China | 2008 |
XtalPi Technology FAQs
-
When was XtalPi Technology founded?
XtalPi Technology was founded in 2015.
-
Where is XtalPi Technology headquartered?
XtalPi Technology is headquartered in Shenzhen, China.
-
What is the size of XtalPi Technology?
XtalPi Technology has 1,623 total employees.
-
What industry is XtalPi Technology in?
XtalPi Technology’s primary industry is Other Healthcare Technology Systems.
-
Is XtalPi Technology a private or public company?
XtalPi Technology is a Public company.
-
What is XtalPi Technology’s stock symbol?
The ticker symbol for XtalPi Technology is 02228.
-
What is the current stock price of XtalPi Technology?
As of 13-Nov-2026 the stock price of XtalPi Technology is $0.75.
-
What is the current market cap of XtalPi Technology?
The current market capitalization of XtalPi Technology is $3.21B.
-
What is XtalPi Technology’s current revenue?
The trailing twelve month revenue for XtalPi Technology is $97.1M.
-
Who are XtalPi Technology’s competitors?
BenevolentAI, InSilico Medicine Cayman, Medkey, Iktos, and Avid Bioservices are some of the 23 competitors of XtalPi Technology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
